Abstract
The normal range, reproducibility, and change as a function of duration and level of injury for Tc-99m-MAG3 renal studies were quantitated in spinal cord injury (SCI) patients. METHODS: Five SCI patients without evidence of renal disease in each of four groups: less than 2 months, 2-12 months, 1-2 years, and greater than 2 years from time of injury, were each studied twice. There were at least two patients with paraplegia and two with tetraplegia in each group. Renal clearance (camera based method), percent function in each kidney, time of peak renal parenchymal activity, and half time of parenchmal activity following the peak were evaluated. The peak and half times were determined with regions of interest (ROIs) over the entire kidney and over just the cortex. All results were compared to normal ranges previously established in normal subjects of the same age range using the same methodology. RESULTS: Renal clearance in the less than 2 month SCI patients was not significantly different from normal subjects in either paraplegic or in tétraplégie individuals. However, clearance in tetraplegics was increased by 28.5% at 2-12 month, increased by 50.6% at 1-2 years, and decreased by 25.9% at greater than 2 years compared to normal subjects (all P<0.02). Clearance in those with paraplegia showed a similar, but less marked, trend (P= NS). The time of peak parenchymal activity when measured with cortical ROIs did not vary among patient groups or level of injury, but was increased compared to normal subjects (P<0.05). The percent function in each kidney and half time following the peak were symmetrical, did not differ among patient groups or with level of injury, and did not differ from normal subjects. The parenchymal peak time was significantly shorter with cortical rather than renal ROIs in all patient groups (P<0.05).
In serial studies in the same patient the percent standard deviation in total renal clearance was less than between single studies in different patients, but the decrease was significant for only the right kidney (P<0.03), and the decrease was not as great as in normal subjects. In addition, the percent standard deviation for percent function in each kidney was significantly less than the percent standard deviations in single studies (P<0.02). There were no significant differences between intra- and interpatient studies for any other parameter. CONCLUSION: We conclude that: (1) renal clearance measured with Tc-99m-MAG3 in tétraplégie patients increases significantly during the first 2 years following injury and decreases significantly thereafter; there is a similar, but much less marked, trend in paraplegics, (2) parenchymal peak times with cortical ROIs occur later for SCI patients than for normal subjects, and (3) there is more intrapatient variation in total renal clearance and percent renal clearance on a side in SCI patients than in normal subjects suggesting that it may be harder to study SCI patients reproducibly. These findings should be taken into account when performing and interpreting Tc-99m-MAG3 renal studies in SCI patients.
Similar content being viewed by others
Article PDF
References
Vera A, Merritt J L, Erickson B R . Renal function in spinal cord injury: A preliminary report. Arch Phys Med Rehabil 1986; 67: 257–259.
Stover S O . Renal function tests on spinal cord injury patients. In Research Update, Spain Rehabilitation Center, Birmington, AL, USA, 1990.
Lloyd A L, Dubovsky C V D, Bueschen A J et al. Comprehensive renal scintillation procedures in spinal cord injury: Comparison with excretory urography. J Urol 1981; 126: 10–13.
Eshima D, Taylor A . Technetium-99m (99mTc) mercaptoacetyltriglycine: Update on the new 99mTc renal tubular function agent. Sem Nucl Med 1992; 22: 61–73.
Klingensmith W C, Briggs D E, Smith W I . Technetium-99m-MAG3 renal studies: Normal range and reproducibility of physiologic parameters as a function of age and sex. J Nucl Med 1994; 35: 1612–1617.
Klingensmith W C, Tyler H N, Marsh W E, et al. Effect of hydration and dehydration on technetium-99m C02 DADS renal studies in normal volunteers. J Nucl Med 1985; 26: 875–879.
Gates G F . Glomerular filtration rate: Estimation from fractional renal accumulation of Tc-99m-DTPA (stannous). Am J Roentgenol 1982; 138: 565–570.
Gates G F . Split renal function testing using Tc-99m DTPA: A rapid technique for determining differential glomerular filtration. Clin Nucl Med 1983; 8: 400–407.
Schlegel J U, Hamway S A . Individual renal plasma flow determination in 2 minutes. J Urology 1976; 116: 282–285.
Harbert J C, Curl F B, Jones G W . The effect of injection volume and technique on radionuclide cerebral angiograms. J Nucl Med 1973; 14: 205–207.
Price M, Tobin J A, Reiser M, et al. Renal function in patients with spinal cord injuries. Arch Phys Med Rehabil 1966; 47: 406–411.
Kuhlemeier K V, McEachran A B, Lloyd A L, et al. Renal function after acute and chronic spinal cord injury. J Urology 1984; 131: 439–445.
Kuhlemeier K V, Lloyd A L, Stover S O . Long-term followup of renal function after spinal cord injury. J Urology 1985; 134: 510–513.
Tempkin A, Sullivan G, Paldi J, et al. Radioisotope renography in spinal cord injury. J Urology 1985; 133: 228–230.
Price M, Kottke F J, Olson M E . Renal function in patients with spinal cord injury: The eighth year of a ten-year continuing study. Arch Phys Med Rehabil 1975; 56: 76–79.
Kolb K W, Ha C Y . Pharmacokinetic and pharmacodynamic alterations in drug therapy caused by spinal cord injury. Phys Med Rehabil 1987; 1: 375–388.
Rabkin R, Dahl D C . Hormones and the kidney. In Diseases of the Kidney, RW Schrier & CW Gottschalk, eds, Little, Brown and Co, Boston, 1993, pp 283–303.
Nuhlicek C N, Spurr G B, Barboriak J J, et al. Body composition of patients with spinal cord injury. Eur J Clin Nutr 1988; 42: 765–773.
Nakamura H, Ebe N, Ito S, et al. Renal effects of different types of protein in healthy volunteer subjects and diabetic patients. Diabetes Care 1993; 16: 1071–1075.
Hostetter T H . Human renal response to a meat meal. Am J Physiol 1986; 250: F613–618.
Bosch J P, Saccaggi A, Lauer A, Ronco C, et al. Renal function reserve in humans. Am J Med 1983; 75: 943–950.
Nair K S, Pabico R C, Truglia J A, et al. Mechanism of glomerular hyperfiltration after a protein meal in humans. Diabetes Care 1994; 17: 711–715.
Wiseman M J, Hunt R, Goodwin A, et al. Dietary composition and renal function in healthy subjects. Nephron 1987; 46: 37–42.
Russell C D, Dubovsky C V D . Measurement of renal function with radionuclides. J Nucl Med 1989; 30: 2053–2057.
Russell C D, Thorstad B L, Yester M V, et al. Quantitation of renal function with technetium-99m MAG3. J Nucl Med 1988; 29: 1931–1933.
Prenen J A C, de Klerk J M H, van het Schip A D, et al Technetium-99m-MAG3 versus iodine-123-OIH: Renal clearance and distribution volume as measured by a constant infusion technique. J Nucl Med 1991; 32: 2057–2060.
Fine E J, Axelrod M, Gorkin J, et al. Measurement of effective renal plasma flow: A comparison of methods. J Nucl Med 1987; 28: 1393–1400.
Russell C D, Dubovsky C V D . Quantitation of renal function using MAG3. J Nucl Med 1991; 32: 2061–2063.
Berriolo A, Touzery C, Riedinger J M, et al. Estimation of Tc-99m-MAG3 plasma clearance from the global renal uptake measured with a gamma camera. Eur J Nucl Med 1991: 32: 619.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klingensmith III, W., Lammertse, D., Briggs, D. et al. Technetium-99m-MAG3 renal studies in spinal cord injury patients: normal range, reproducibility, and change as a function of duration and level of injury. Spinal Cord 34, 338–345 (1996). https://doi.org/10.1038/sc.1996.62
Issue Date:
DOI: https://doi.org/10.1038/sc.1996.62